Some investors asked Entropy-based Technology, were the chips designed by the company's brain-computer products developed and produced in-house? Does the technical content have a competitive advantage compared to peers? Do brain-computer products generate sales revenue? Has a global sales network been set up? How to participate in international competition? On November 9, the company replied that the chips for brain computer products are self-developed and imported. The company's EEG modules have achieved a small amount of sales. This portion of revenue currently accounts for a low proportion of the company's revenue. The company relies on differentiation capabilities such as multi-modal BioCV and advantages such as a mature global sales network to promote the implementation of the brain-computer business. As a cutting-edge technology field, brain-computer interfaces still face uncertainty in various aspects such as technology iteration, market acceptance, and industrialization process. The company reminds investors of investment risks.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.